Bhatia, J., Bedano, P. M., Bhatia, S., Leslie, J., Garcia-Manero, G., Pemmaraju, N., Wolfe, Z., Socec, C., Kadia, T. M. (2026). Cladribine (CLAD) + low-dose AraC (LDAC) + venetoclax (VEN) in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome: Real-world analysis from a large community-based oncology practice.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6542